NCT07021534
Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial
Phase: Phase 1
Role: Collaborator
Start: Jun 10, 2025
Completion: Dec 31, 2026